Results 121 to 130 of about 801 (188)

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations. [PDF]

open access: yesActa Derm Venereol
Gil-Lianes J   +9 more
europepmc   +1 more source

Genetic Predictors of Progression and Skin Rash in Japanese mCSPC Patients Treated With Apalutamide: CUARTET Study. [PDF]

open access: yesCancer Sci
Shiota M   +8 more
europepmc   +1 more source

Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer. [PDF]

open access: yesCancer Med
Miura H   +12 more
europepmc   +1 more source

Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC. [PDF]

open access: yesJpn J Clin Oncol
Tohi Y   +23 more
europepmc   +1 more source

Outcomes for [<sup>177</sup>Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer. [PDF]

open access: yesEur Urol Oncol
Muniz M   +15 more
europepmc   +1 more source

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. [PDF]

open access: yesClin Cancer Res
McHugh D   +33 more
europepmc   +1 more source

Real-world clinical outcomes of apalutamide versus abiraterone with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. [PDF]

open access: yesInt J Clin Pharm
Pons-Fuster E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy